The Medical Device Market: Australia

Publisher Name :
Date: 29-Jan-2014
No. of pages: 149

Overview

Australia is one of the richest healthcare markets in the Asia-Pacific region. The market ranks amongst the top 20 largest in the world, while per capita spending is on a par with European markets such as the Netherlands or Finland.

Around 75% of the market is located in the three states of New South Wales, Victoria and Queensland, situated on the south and east coasts. Much of the rest of the country is very sparsely inhabited. Healthcare provision is a mixture of public and private. Public expenditure is largely funded by the Commonwealth (central) Government, while private expenditure is largely funded through insurance.

While there are a few small high tech manufacturers, local production tends to concentrate on basic hospital supplies. The market is therefore predominantly supplied by imports, which have grown rapidly since 2001. Imports are principally supplied by the USA, with which Australia has developed close trading links.

In August 2011, after months of negotiation, the Commonwealth Government signed an agreement with all States and Territories to formalise the National Health Reform plan. Designed to improve funding to hospitals and to reduce patient waiting times, the plan will see the Commonwealth Government invest at least A$16.4 billion (US$16.0 billion) in additional funding for public hospitals over the period 2014-15 to 2019-20. The Commonwealth Government will match 45% of efficient growth funding from July 2014, and 50% of efficient growth from July 2017.

The Medical Device Market: Australia

Table of Contents

Espicom Industry View   7
Espicom Industry View      7
SWOT     9
Medical Device Market      9
Political     10
Economic    11
Business Environment     12
Industry Forecast     14
Medical Device Market Forecast    14
Table: Projected Medical Device Market, 2013-2018     16
Table: Detailed Medical Device Market By Product Area, 2008-2018 (US$mn)   17
Table: Detailed Medical Device Market By Product Area, 2008-2018 (US$ Per Capita)  21
Table: Detailed Medical Device Market By Product Area, 2008-2018 (% Of Total)     24
Table: Detailed Medical Device Market By Product Area, 2009-2018 (US$, % Change)  28
Consumables Market Forecast    31
Table: Consumables Market, 2008-2018 (US$mn)  32
Table: Consumables Market, 2008-2018 (US$ Per Capita)    33
Table: Consumables Market, 2009-2018 (US$mn % Change)    34
Diagnostic Imaging Market Forecast     36
Table: Diagnostic Imaging Market, 2008-2018 (US$mn)     38
Table: Diagnostic Imaging Market, 2008-2018 (US$ Per Capita)   39
Table: Diagnostic Imaging Market, 2009-2018 (US$mn % Change)     40
Dental Products Market Forecast   42
Table: Dental Products Market, 2008-2018 (US$mn)     43
Table: Dental Products Market, 2008-2018 (US$ Per Capita)  43
Table: Dental Products Market, 2009-2018 (US$mn % Change)     44
Orthopaedics & Prosthetics Market Forecast  46
Table: Orthopaedics & Prosthetics Market, 2008-2018 (US$mn)   47
Table: Orthopaedics & Prosthetics Market, 2008-2018 (US$ Per Capita)   47
Table: Orthopaedics & Prosthetics Market, 2009-2018 (USmn % Change)      48
Patient Aids Market Forecast     49
Table: Patient Aids Market, 2008-2018 (US$mn)    50
Table: Patient Aids Market, 2008-2018 (US$ Per Capita)   50
Table: Patient Aids Market, 2009-2018 (US$mn % Change)   51
Other Medical Devices Market Forecast    53
Table: Other Medical Devices Market, 2008-2018 (US$mn)   54
Table: Other Medical Devices Market, 2008-2018 (US$ Per Capita)  55
Table: Other Medical Devices Market, 2009-2018 (US$mn % Change)      56
Annual Medical Device Imports     59
Table: Medical Device Imports By Product Area, 2008-2012 (US$000s)      62
Table: Medical Device Imports By Product Area 2008-2012 (US$000s, % Change)     63
Table: Medical Device Imports By Product Area, 2008-2012 (Local Currency 000s)     64
Table: Medical Device Imports By Product Area, 2008-2012 (Local Currency 000s, % Change)      65
Table: Medical Device Imports By Product Area, 2008-2012 (% Distribution)      66
Table: Leading Medical Device Suppliers By Product Area (US$000s)      67
Table: Leading Medical Device Suppliers By Product Area (% Distribution)      68
Table: Top 20 Medical Device Suppliers (US$000s)  69
Table: Detailed Medical Device Imports By Product Area, 2008-2012 (US$000s)  70
Table: Detailed Medical Device Import Trends By Product Area   73
Table: Detailed Leading Medical Device Suppliers By Product Area (US$000s)      76
Monthly Medical Device Imports    80
Table: Monthly Medical Device Imports By Product Area, June 2010-June 2013 (US$mn)     80
Annual Medical Device Exports     82
Table: Medical Device Exports By Product Area, 2008-2012 (US$000s)      84
Table: Medical Device Exports By Product Area, 2008-2012 (US$000s, % Change)  85
Table: Medical Device Exports By Product Area, 2008-2012 (Local Currency 000s)     86
Table: Medical Device Exports By Product Area, 2008-2012 (Local Currency 000s, % Change)      87
Table: Medical Device Exports By Product Area, 2008-2012 (% Distribution)      88
Table: Leading Medical Device Destinations By Product Area (US$000s)   89
Table: Leading Medical Device Destinations By Product Area (% Distribution)      90
Table: Top 20 Medical Device Destinations (US$000s)     91
Table: Detailed Medical Device Exports By Product Area, 2008-2012 (US$000s)  92
Table: Detailed Medical Device Export Trends By Product Area   95
Table: Detailed Leading Medical Device Destinations By Product Area (US$000s)     99
Table: Detailed Medical Device Balance Of Trade, 2008-2012 (US$000s)   102
Monthly Medical Device Exports     105
Table: Monthly Medical Device Exports By Product Area, June 2010-June 2013 (US$mn)  105
Macroeconomic Forecasts  108
Economic Analysis   108
Can The Construction Sector Do The Heavy-Lifting?   109
Still Downbeat On Housing Market     110
Constrained Government Policies Unlikely To Lift Building Demand    111
Chinese Stimulus Presents Upside Risks To Outlook      112
Table: Australia - Economic Activity   113
Industry Risk Reward Ratings      114
Industry Risk Reward Ratings   114
Table: Espicom Analysis of the Australian Medical Market, 2013      114
Market Overview     116
Medical Device Market Overview     116
Table: Medical Device Market, Key Ratios    117
Table: Medical Device Market By Product Area    118
Healthcare Overview     120
Table: Diagnostic Imaging Technology By Type, 2006-2012    123
Table: Diagnostic Imaging Technology Per Million Population By Type, 2006-2012  123
Table: Key Data, 2008-2013  124
Industry Trends & Developments   127
Industry Trends & Developments     127
Regulatory Development  131
Medical Device Regulations     131
Competitive Landscape   134
Domestic Medical Device Production    134
National Medical Device Manufacturers     134
Multinational Medical Device Manufacturers  138
Multinational Market Activity   140
Table: Multinational Market Activity, 2013  140
Methodology     142
Table: Used HS Trade Codes, 2013     143
Table: Rearranged HS Trade Codes, 2013    145

  • Challenges in the Tourism Industry in Thailand
    Thailand has always been a popular tourist destination and tourism provides a major boost to the country’s economy. Bangkok, Hua Hin, Krabi, Samui, Phuket and Cha Am are some of the most attractive tourist destinations in the country. In 2012, Thailand had a very high number of arrivals. Even the number of Thai citizens who [...]
  • Future of the US Consumer Electronics Market
    The market for consumer electronics has been growing steadily. Some of the factors that are contributing to the growth in the market are technological advancement, rise in disposable income and increasing demand for new products. During 2012, consumer electronics market in the US demonstrated positive expansion, although the growth rate slowed down considerably following the [...]
  • Overview of the Global Retail Market
    The global retail industry continued to grow despite the difficult economic conditions in the world. In the fiscal year of 2011, sales-weighted, currency-adjusted revenue rose by 5.1% to $4.271 trillion for the world’s top 250 retailers. According to GRDI (Global Retail Development Index), in 2013 Brazil occupied the top spot in retail development. Chile and [...]
  • Bright Future Predicted for the Tourism Industry in Singapore
    Travel and tourism industry in Singapore has been growing at a steady rate and is considered to be a major contributor to the economic growth of the country. In 2012, Singapore’s IVA (International Visitors Arrivals) reached a record high of 14.5 million, with a growth rate of 10.1% year-on-year. In recent years, inbound travel to [...]
  • Potential of Staffing Market in United States
    The staffing industry places individuals into contract, temporary and permanent positions in firms around the world. Major staffing markets include France, Spain, Italy and Japan as well as many emerging markets. Temporary staffing around the world has been growing, but in US temporary market has been flat since 2006. The majority of staffing revenue majorly [...]
  • Graft-Versus-Host Disease (GVHD) Treatment Market worth $407 million by 2018
  • The graft-versus-host disease (GVHD) treatment market value will increase from $297 million in 2013 to $407 million by 2018, at a Compound Annual Growth Rate (CAGR) of 6.59%, according to research and consulting firm GlobalData. The company’s latest report* states …

  • Poland Pharmaceutical Industry Growing at 8.3% CAGR to 2020
  • Factors such as the growing elderly population, increasing availability of affordable medicines, and transparent regulatory guidelines will provide the necessary impetus for the growth of the Polish pharmaceutical market, but a decrease in mark-up prices and the country’s stringent drug …

  • Asia-Pacific, Led by China, Drive the Global Methanol Industry
  • China is driving the global methanol industry, with tremendous demand from both its energy and petrochemicals sectors. It accounts for 87.9% of Asia-Pacific’s (APAC) methanol capacity, and 51.9% of the global methanol capacity. Despite a large planned capacity increase in …

  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Graft-Versus-Host Disease Market Forecast to 2023
  • Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either …

  • Non-Hodgkin Lymphoma Therapeutics in Major Developed Markets to 2020 – New Entrants and Promising Pipeline Widen Targeted and Immunotherapeutic Treatment Options
    Published: 29-Oct-2014        Price: US $4995 Onwards        
    GBI Research, a leading business intelligence provider, has released its latest research report: “Non-Hodgkin Lymphoma Therapeutics in Major Developed Markets to 2020 - New Entrants and Promising Pipeline Widen Targeted and Immunotherapeutic Treatment Options”, which provides in-depth insight into the indication. It provides estimates of market size for 2013 along with forecasts until 2020 for the eight major developed markets, which comprises the US, UK, France, Germany, Italy, Spain, Japan......
  • Cell Expansion Market by Product (Reagent, Media, Serum, Bioreactors, Centrifuge), Cell Type (human, animal), Application (Stem Cell Research, Regenerative Medicine, Clinical Diagnostics), End User (Hospital, Biotechnology, Cell Bank) – Forecast to 2019
    Published: 29-Oct-2014        Price: US $4650 Onwards        Pages: 224
    The global cell expansion market is expected to reach $14.8 billion by 2019 from $6.0 billion in 2014, growing at a CAGR of 19.7% from 2014 to 2019. The global cell expansion market is categorized on the basis of product, cell type, application, end user, and geography. The human cell expansion segment is expected to register the highest growth rate in the cell expansion market, by cell type, during the forecast period. Its favorable growth is attributed to increasing focus on human stem cell re......
  • Aortic Stent Grafts – Current and Future Players
    Published: 29-Oct-2014        Price: US $3500 Onwards        Pages: 106
    Aortic stent grafts are most commonly used to reinforce a weak spot in an artery, which is known as an aneurysm. The stent grafts are designed to seal tightly with the patient’s native artery above and below the aneurysm, and are used to treat abdominal aortic aneurysms as well as thoracic aortic aneurysms. Aortic aneurysms, as opposed to aneurysms found elsewhere in the body, are potentially very serious, as a burst aorta results in massive internal bleeding that can be fatal unless treated r......
  • Identifying and Commercializing First-in-Class Innovation in Non-Small-Cell Lung Carcinoma
    Published: 29-Oct-2014        Price: US $6995 Onwards        
    Large Degree of Innovation in NSCLC Pipeline The NSCLC pipeline currently has 389 products in active development across all stages, but a stark contrast between the mechanisms of action employed in the current market and the pipeline is evident. Where the market comprises primarily ineffective chemotherapies that target tubulin or DNA replication, the pipeline shows an incredibly diverse range of therapies targeting multiple signaling pathways and molecules integral to cancer development. Thi......
  • Global Biologic Therapeutics Market 2014-2018
    Published: 29-Oct-2014        Price: US $3500 Onwards        Pages: 185
    Biologic therapeutics include virus, therapeutic serum, toxin, allergenic product, antitoxin, blood component or derivative, vaccine, blood, protein (except any chemically synthesized polypeptide), or analogous product, or arsphenamine or derivative of arsphenamine (or any other trivalent organic arsenic compound), intended for the prevention, treatment, or cure of a disease or condition. These products differ from small molecules in terms of molecular weight, structure, synthesis, and immunogen......
  • Egypt Pharmaceuticals and Healthcare Report Q4 2014
    Published: 29-Oct-2014        Price: US $1295 Onwards        Pages: 126
    BMI View: Egypt's relative political stability will lead to a pickup in growth over the coming quarters, increasing the attractiveness of the pharmaceutical market - for which our forecast has been revised slightly upwards. The government's increased emphasis on developing the pharmaceutical sector and the announced expansion of the Medicare healthcare programme are positive developments this quarter. The challenges faced by pharmaceutical companies wishing to operate in the market are the c......
  • Global Pharmaceutical Packaging Market 2014-2018
    Published: 29-Oct-2014        Price: US $2500 Onwards        Pages: 77
    A pharmaceutical product is any chemical substance formulated or compounded as a single active ingredient. The packaging of medicines is a very complex process, and because of its molecular and chemical structure, it needs to be packed in an extremely durable material so that it could reach the customer in a desirable condition. The evolution of new diseases and increased health awareness have brought a transformation in the Pharmaceutical Packaging market. The vendors in the Global Pharmaceutic......
  • Indonesia Pharmaceuticals and Healthcare Report Q4 2014
    Published: 29-Oct-2014        Price: US $1295 Onwards        Pages: 142
    BMI View: Indonesia is one of the most promising markets for the pharmaceutical and healthcare companies in South East Asia. The country's large population, positive economic outlook and considerable disease burden bode well for growth in demand for drugs, medical devices and healthcare services. The ongoing implementation of the universal healthcare scheme in Indonesia coupled with the impending launch of the ASEAN Economic Community will provide growth opportunities for pharmaceutical firm......
  • Global Polymerase Chain Reaction (PCR) Market 2014-2018
    Published: 29-Oct-2014        Price: US $2500 Onwards        Pages: 75
    Polymerase Chain Reaction (PCR) is a technique of molecular genetics, which allows amplification and analysis of nucleic acid. It is very precise, specific and accurate technique used to amplify a specific DNA target from a mixture of DNA molecules. It is used in a wide array of applications in research and diagnosis, including genetic engineering, cloning, sequencing, diagnosis, genotyping, and many other areas. Advances in PCR technology and tools provide high reproducibility within a short pe......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs